The DOI matches its Crossref record.
Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms
Open accessAbstract
Objective: Neuromyelitis optica (NMO) is a neuroinflammatory disease of spinal cord and optic nerve associated with serum autoantibodies (NMO–immunoglobulin G [IgG]) against astrocyte water channel aquaporin‐4 (AQP4). Recent studies suggest that AQP4 autoantibodies are pathogenic. The objectives of this study were to establish an ex vivo spinal cord slice model in which NMO‐IgG exposure produces lesions with characteristic NMO pathology, and to test the involvement of specific inflammatory cell types and soluble factors. Methods: Vibratome‐cut transverse spinal cord slices were cultured on transwell porous supports. After 7 days in culture, spinal cord slices were exposed to NMO‐IgG and complement for 1 to 3 days. In some studies inflammatory cells or factors were added. Slices were examined for glial fibrillary acidic protein (GFAP), AQP4, and myelin immunoreactivity. Results: Spinal cord cellular structure, including astrocytes, microglia, neurons, and myelin, was preserved in culture. NMO‐IgG bound strongly to astrocytes in the spinal cord slices. Slices exposed to NMO‐IgG and complement showed marked loss of GFAP, AQP4, and myelin. Lesions were not seen in the absence of complement or in spinal cord slices from AQP4 null mice. In cultures treated with submaximal NMO‐IgG, the severity of NMO lesions was increased with inclusion of neutrophils, natural killer cells, or macrophages, or the soluble factors tumor necrosis factor α (TNFα), interleukin‐6 (IL‐6), IL‐1β, or interferon‐γ. Lesions were also produced in ex vivo optic nerve and hippocampal slice cultures. Interpretation: These results provide evidence for AQP4, complement‐ and NMO‐IgG–dependent NMO pathogenesis in spinal cord, and implicate the involvement of specific immune cells and cytokines. Our ex vivo model allows for direct manipulation of putative effectors of NMO disease pathogenesis in a disease‐relevant tissue. ANN NEUROL 2011
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Aquaporin 4 and neuromyelitis optica
Papadopoulos, M. C., & Verkman, A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70133-3 · Cited by 597
Self-citationJarius, S., Paul, F., Weinshenker, B. G., Levy, M., Kim, H. J., & Wildemann, B. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0214-9 · Cited by 478
Neuromyelitis optica: clinical features, immunopathogenesis and treatment
Jarius, S., Wildemann, B., & Paul, F. (2014) · Clinical and Experimental Immunology · doi:10.1111/cei.12271 · Cited by 342
Treatment of neuromyelitis optica: state-of-the-art and emerging therapies
Papadopoulos, M. C., Bennett, J. L., & Verkman, A. S. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.141 · Cited by 262
Self-citationAnti–Aquaporin‐4 monoclonal antibody blocker therapy for neuromyelitis optica
Tradtrantip, L., Zhang, H., Saadoun, S., Phuan, P., Lam, C., Papadopoulos, M. C., Bennett, J. L., & Verkman, A. S. (2012) · Annals of Neurology · doi:10.1002/ana.22657 · Cited by 253
Self-citation
Metadata
- Authors
- Zhang, H., Bennett, J. L., & Verkman, A. S.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2011-11-08
- Volume
- 70
- Issue
- 6
- Pages
- 943-954
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2018439132
- Cited by
- 168
- References
- 0
- FWCI
- 10.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms. https://app.cochat.ai/papers/10.1002/ana.22551
- The paper
- Zhang, H., Bennett, J. L., & Verkman, A. S. (2011). Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms. Annals of Neurology. https://doi.org/10.1002/ana.22551
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.